ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2094

Cross-sectional Associations of Radiographic Multiple Joint Osteoarthritis and Pain with Demographic and Clinical Characteristics: Design of a Multi-modal Study in Human and Pet Dogs

Liubov Arbeeva1, Kelly Johnson2, Serena Savage-Guin3, Tessa Walker2, Masataka Enomoto4, Christina Stevens4, Milja Koskinen4, Tracey Cole4, Savannah Aker4, Connor Thonen-Fleck4, Richard Loeser5, Jordan Renner2, Duncan Lascelles6, Yvonne Golightly7 and Amanda Nelson8, 1University of North Carolina, Chapel Hill, Carrboro, NC, 2Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill,, Chapel Hill, NC, 4Translational Research in Pain and Comparative Pain Research and Education Center, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 5University of North Carolina, Chapel Hill, NC, 6North Carolina State University, Raleigh, NC, 7University of Nebraska Medical Center, Omaha, NE, 8University of North Carolina at Chapel Hill, Chapel Hill, NC

Meeting: ACR Convergence 2024

Keywords: Biomarkers, metabolic syndrome, microbiome, Osteoarthritis, pain

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Multiple joint osteoarthritis (MJOA) is a progressive, highly prevalent disease affecting millions of Americans and as well as pet dogs. This preliminary analysis sought to introduce and describe a new, actively enrolling study that aims to define biomarkers predictive of development and worsening of MJOA. Specifically, we describe the frequency of radiographic MJOA (rMJOA) and symptoms in 100 Johnston County Health Study (JoCoHS) human participants and 115 pet dogs independently enrolled at the NC State University (NCSU) College of Veterinary Medicine.

Methods: All JoCoHS participants enrolled in this study (N=100) provided demographic, clinical information, anthropometric, symptomatic and functional assessments, and multiple joint radiographs. Blood, urine, and stool samples were collected for measures of biomarkers, cytokines and microbiota profiling. Similar data were collected from an independent group of pet dogs (N=115) recruited from NCSU. The number of painful joints was calculated from a map, which involves a graphical representation of unilateral and bilateral joints. For MJOA, we specified unique joint sites, such that involvement of the bilateral joints counted as a single site rather than two joints. rMJOA was defined as at least 3 unique appendicular joint sites involved in both humans and dogs. If at least one of these sites was associated with pain, it was considered symptomatic (sxMJOA). Descriptive statistics were calculated for demographic characteristics, radiographic and symptomatic measures, and lab values (liver enzymes, albumin, platelets) using means and standard deviations for continuous, frequencies and percentages for categorical variables. No statistical comparisons were performed in this descriptive abstract.

Results: One hundred human participants (63% men, 33% Black, 13% Hispanic; mean age 56 yrs) enrolled in the JoCoHS, and 115 dogs enrolled through NCSU (40% spayed females, 57% neutered males, 3% intact males, mean age 8 yrs, 49% mixed breed) were included. The frequency (n, %) of joint-specific human OA and the distribution of the number of joints involved are shown in Figure 1. One in 5 (21%) JoCoHS participants had rMJOA, with 13 participants having sxMJOA (13%). Among 100 participants, the mean number of painful joints was 8 (SD=6).

The frequency of joint-specific OA in 115 dogs and the distribution of the number of joints affected are shown in Figure 2. rMJOA was present in 25 (22%) dogs, 24 of them had sxMJOA. Among 115 dogs, the mean number of painful appendicular joints was 4 (range 0-12).

The lab values demonstrate expected ranges for these population-based cohorts, including mostly normal liver function, without significant differences by hyperglycemia status (Figure 3, A: Humans; B: Dogs).

Conclusion: These two population-based cohorts demonstrated similar frequencies of rMJOA (~20%) and similar number of joints involved supporting the use of dogs to model MJOA. Their basic laboratory values are consistent with the community-based nature of enrollment, and support generalizability of results. Samples from these cohorts are undergoing analysis to understand associations between MJOA and biomarkers, cytokines, dysbiosis, and intestinal permeability.

 

Supporting image 1

Figure 1. Affected joint sites and overall pattern in human participants. CMC : Carpometacarpal Joint; DIP: Distal Interphalangeal Joint; OA: Osteoarthritis; PIP: Proximal Interphalangeal Joint.

Supporting image 2

Figure 2. Affected joint sites and overall pattern in pet dog participants. OA: Osteoarthritis.

Supporting image 3

Figure 3. Summary of laboratory values among human (A) and pet dog (B) study participants by diabetes (self-report and/or HgbA1c >= 6.5% in humans)/blood glucose status (>126 mg/dL in dogs).


Disclosures: L. Arbeeva: None; K. Johnson: None; S. Savage-Guin: None; T. Walker: None; M. Enomoto: None; C. Stevens: None; M. Koskinen: None; T. Cole: None; S. Aker: None; C. Thonen-Fleck: None; R. Loeser: None; J. Renner: None; D. Lascelles: None; Y. Golightly: None; A. Nelson: MedScape Education, 6, NestleHealth, 6.

To cite this abstract in AMA style:

Arbeeva L, Johnson K, Savage-Guin S, Walker T, Enomoto M, Stevens C, Koskinen M, Cole T, Aker S, Thonen-Fleck C, Loeser R, Renner J, Lascelles D, Golightly Y, Nelson A. Cross-sectional Associations of Radiographic Multiple Joint Osteoarthritis and Pain with Demographic and Clinical Characteristics: Design of a Multi-modal Study in Human and Pet Dogs [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/cross-sectional-associations-of-radiographic-multiple-joint-osteoarthritis-and-pain-with-demographic-and-clinical-characteristics-design-of-a-multi-modal-study-in-human-and-pet-dogs/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cross-sectional-associations-of-radiographic-multiple-joint-osteoarthritis-and-pain-with-demographic-and-clinical-characteristics-design-of-a-multi-modal-study-in-human-and-pet-dogs/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology